TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02711202 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01122225 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01122225 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04600947 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04459936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00836407 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01523652 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01467297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01467297 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03856411 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03856411 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04513301 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04513301 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03864419 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03793608 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01552161 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT00004667 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02872779 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02872779 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03281174 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03982992 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02790164 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT00001630 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02260661 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02260661 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03731156 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT04004481 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01473264 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT04238819 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03885843 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00654095 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02436928 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03234543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03234543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00795262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01202175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01202175 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01059656 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study NCT01059656 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01059656 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01059656 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01059656 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT02392481 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03334513 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04335955 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04335955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04335955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03413462 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00738179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04230928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00404287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00003992 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01875666 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04532281 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00153179 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05409729 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00129389 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02063568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03611946 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03600220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00698139 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01080625 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00973882 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00785005 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02676050 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04460300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01984359 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT03289494 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT03783013 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01166386 — Predictive Biomarker (PRD): FANCI mRNA
Genes: FANCI; KIAA1794
Study NCT03617458 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01156545 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00273650 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01654328 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03765177 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03885076 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03885076 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02705755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03751072 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01940380 — Predictive Biomarker (PRD): LTBP1 mRNA
Genes: LTBP1
Study NCT01424306 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01353430 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study NCT00013949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01377324 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01377324 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04361721 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study NCT04071639 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00369889 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00369889 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02912624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03351062 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03351062 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01942395 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04591704 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03602638 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00604357 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02653625 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT03988894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004356 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT04999059 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT04999059 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT02205073 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT03593005 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01988181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03244306 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02613247 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01110590 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT04261062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00908544 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00908544 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01541085 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00124748 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03267576 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00542425 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04527666 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02515331 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04142762 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03831711 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01269827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01269827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02871791 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02871791 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02871791 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02871791 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05103995 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT00608491 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00608491 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00608491 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03221920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02486042 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03854903 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03854903 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03854903 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03854903 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02269982 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02890173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02945241 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00204490 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01880866 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01880866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01880866 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06059274 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04800081 — Safety Biomarker (SAF): Urinary microalbumin
Study NCT03453255 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00043303 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00974116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03376893 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04085991 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02513394 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02513394 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02513394 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02513394 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02556346 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00747708 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00747708 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01581606 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03751501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02766270 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT03931889 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT03931889 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04502199 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT00215228 — Predictive Biomarker (PRD): NE
Study NCT01087073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03275493 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01513629 — Predictive Biomarker (PRD): CNTNAP2 mRNA
Genes: CNTNAP2; CASPR2; KIAA0868
Study NCT01513629 — Predictive Biomarker (PRD): SLC25A12 mRNA
Genes: SLC25A12; AGC1; ARALAR1
Study NCT03266367 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04127578 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT00485121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00485121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03442933 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT03052634 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00983242 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04280081 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT00352846 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01506505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02570464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02570464 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00755742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03283527 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT00906828 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00302861 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01059461 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00118924 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02233244 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02819583 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02729298 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT02729298 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02729298 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02729298 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01599273 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06371989 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06371989 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04877119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT02251795 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02096666 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03237390 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01092364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01614522 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02650193 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03391375 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04520295 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00343395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02163044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02476019 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02554201 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study NCT02056249 — Predictive Biomarker (PRD): NE
Study NCT03229876 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01985204 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00691730 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00444834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01452243 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01428414 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04469556 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04330040 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03712670 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00218933 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02106845 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT01199198 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01337791 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01228786 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01228786 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT02518061 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02518061 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02158195 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03943940 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00566332 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00566332 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT02331706 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00901394 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01620658 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT02765854 — Predictive Biomarker (PRD): NFKB2 mRNA
Genes: NFKB2; LYT10
Study NCT00444951 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT01947868 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02479386 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study NCT02479386 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04347434 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00971191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03849014 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03849014 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04246489 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03817749 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01145404 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01145404 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01437059 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT00896662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03352167 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT01359527 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01541540 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00621244 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT00064987 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study NCT01957514 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03620292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03620292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03620292 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03620292 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03620292 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF